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globular domain
Abstract
The structure of the N-terminal region of mouse alpha-dystroglycan (DGN) was investigated by
expression of two protein fragments (residues 30-180 and 30-438) in Escherichia coli cells. Trypsin
susceptibility experiments show the presence of a stable alpha-dystroglycan N-terminal region
(approximately from residue 30 to 315). In addition, guanidinium hydrochloride (Gdn/HCl) denaturation
of DGN-(30-438)-peptide, monitored by means of tryptophan fluorescence, produces a cooperative
transition typical of folded protein structures. These results strongly suggest that the alpha-dystroglycan
N-terminal is an autonomous folding unit preluding a flexible mucin-like region and that its folding is
not influenced by the absence of glycosylation. In order to obtain more information on the structural
features of the N-terminal domain we have also used circular dichroism, analytical sedimentation and
electron microscopy analysis. Circular dichroic spectra show the absence of typical secondary structure
(e.g. alpha-helix or beta-sheet) and closely resemble those recorded for loop-containing proteins. This is
consistent with a sequence similarity of the alpha-dystroglycan domain with the loop-containing protein
elastase. Analytical ultracentrifugation and electron microscopy analysis reveal that the N-terminal
domain has a globular structure. DGN-(30-438)-peptide does not bind in the nanomolar range to an
iodinated agrin fragment which binds with high affinity to tissue purified alpha-dystroglycan. No
binding was detected also to laminin. This result suggests that the alpha-dystroglycan N-terminal
domain does not contain the binding site to its extracellular matrix binding partners. It is less likely than
the lack of glycosylation reduces its binding affinity, because the N-terminal globular domain only
contains two glycosylation sites.
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The structure of the N-terminal region of mouse tr-dystroglycan (DGN) was investigated by expression 
of two protein fragments (residues 30- 180 and 30-438) in Eschericlzia coli cells. Trypsin susceptibility 
experiments show the presence of a stable a-dystroglycan N-terminal region (approximately from residue 
30 to 31.5). In addition, guanidinium hydrochloride (Gdn/HCI) denaturation of DGN-(30-438)-peptide, 
monitored by means of tryptophan fluorescence, produces a cooperative transition typical of folded pro- 
tein structures. These results strongly suggest that the a-dystroglycan N-terminal is an autonomous folding 
unit preluding a flexible mucin-like region and that its folding is not influenced by the absence of glycosy- 
lation. In order to obtain more information on the structural features of the N-terminal domain we have 
also used circular dichroism, analytical sedimentation and electron microscopy analysis. Circular dichroic 
spectra show the absence of typical secondary structure (e.g. a-helix or P-sheet) and closely resemble 
those recorded for loop-containing proteins. This is consistent with a sequence similarity of the a-dystro- 
glycan domain with the loop-containing protein elastase. Analytical ultracentrifugation and electron mi- 
croscopy analysis reveal that the N-terminal domain has a globular structure. DGN-(30-438)-peptide 
does not bind in the nanomolar range to an iodinated agrin fragment which binds with high affinity to 
tissue purified a-dystroglycan. No binding was detected also to laminin. This result suggests that the a- 
dystroglycan N-terminal domain does not contain the binding site to its extracellular matrix binding 
partners. It is less likely than the lack of glycosylation reduces its binding affinity, because the N-terminal 
globular domain only contains two glycosylation sites. 
Keywords: a-dystroglycan ; recombinant expression ; fluorescence ; circular dichroism ; electron micro- 
scopy. 
a-Dystroglycan, a highly 0- and N-glycosylated peripheral 
membrane protein, is tightly associated with the membrane- 
spanning /?-dystroglycan to form part of the dystrophin-glyco- 
protein complex (Ervasti and Campbell, 1991 ; Ibraghimov-Be- 
skrovnaya et al., 1992; Tinsley et al., 1994). This complex also 
includes the membrane-spanning a, P and y sarcoglycans and a 
2.5-kDa non-glycosylated protein and constitutes a crucial mo- 
lecular linker between the extracellular matrix and the internal 
cytoskeleton (Ervasti and Campbell, 1993). In particular, a- 
dystroglycan directly connects viu calcium-dependent laminin 
binding basement membranes to the cells, providing mechanical 
stability to several different tissues (Ervasti and Campbell, 1993 ; 
Durbeej et al., 199.5). a-Dystroglycan binds to globular G-do- 
mains which are present at the C-terminal of both laminin and 
agrin (Gee et al., 1993; Brancaccio et al., 199.5a; Gesemann et 
al., 1996) but it is not yet known which region of a-dystroglycan 
is responsible for this activity. 
From the deduced amino acid sequence a-dystroglycan mo- 
lecular mass is =74 kDa but the protein is highly O-glycosy- 
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Note. The amino acid sequence published here has been deposited 
with the EMBL data bank and is available under accession number 
X86073. 
lated. There are two consensus sequences (Asn-Xaa-Ser) for N- 
glycosylation, the first in the N-terminal region and the other in 
the C-terminal one. In skeletal muscle glycosylation amounts to 
=SO% of the total mass (-1.56 kDa) and even the least glycosy- 
lated form from brain (total mass =120 kDa) contains -40% 
carbohydrates (Ibraghimov-Beskrovnaya et al., 1992). Glycosy- 
lation seems to be crucial for dystroglycan function and prevents 
fragmentation of the protein (Ervasti and Campbell, 1991, 1993 ; 
Henry and Campbell, 1996). Its glycosylation pattern is poorly 
understood, but a recent carbohydrate analysis points towards 
the presence of extensive mucin-like 0-glycosylation (Smal- 
haiser and Kim, 1995). a-Dystroglycan could harbour heparan- 
sulphate glycosaminoglycan chains since heparin inhibits its 
binding to laminin and agrin (Gee et al., 1993; Brancaccio et 
al., 199Sa). Heparan sulphate may not however be directly in- 
volved in binding because the a-dystroglycan-binding site of 
agrin is close to but separated from the heparin-binding site 
(Gesemann et al., 1996). 
The structural organization of a-dystroglycan has not yet 
been clarified. No similarity to other proteins has been found 
(Ibraghimov-Beskrovnaya et al., 1992; Henry and Campbell, 
1996). Only for the central part with a high fraction of Pro and 
Thr, a mucin-like structure (Hilkens et al., 1992; Gum et al., 
1992; Li et al., 1996) has been proposed (Brancaccio et al., 
199Sa). The dumbbell-like shape of two globes connected by an 
elongated rod supports this notion (Brancaccio et al., 1995a). 
To investigate whether in a-dystroglycan the N-terminal re- 
gion folds autonomously, we decided to express in Escherichia 
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coli two N-terminal fragments of mouse a-dystroglycan whose 
cDNA sequence we have recently cloned and sequenced (Bran- 
caccio et al., 1995b). Our results indicate that the N-terminal 
part of cx-dystroglycan (a) is able to fold even in the absence of 
glycosylation; (b) has a globular shape and structural features 
similar to those of loop-containing proteins; and (c) does not 
bind to agrin and laminin in a nanomolar concentration range. 
Preliminary results have been presented at the XVth Meeting 
of the Federation of the European Connective Tissue Societies 
(Munich, August 4th to 9th, 1996). 
MATERIALS AND METHODS 
Expression and purification of recombinant a-dystrogly- 
can fragments. The full-length cDNA sequence for a-dystrogly- 
can was generated from the murine skeletal muscle cell line 
C2C12 using reverse-transcriptase PCR standard procedures, 
and further cloned in the pGEM vector (Promega) as described 
elsewhere (Brancaccio et al., 1995b). This sequence was used 
as a PCR template to generate the DNA constructs encoding the 
N-terminal protein fragments. For cloning purposes DGN-(30- 
180)-peptide starts with foreign residues Gly-Ser and DGN- 
(30-438)-peptide with Gly-Ser-Arg-Val-Asp. Oligonucleotide 
primers were used to amplify the sequences of interest. For 
DGN-(30-180)-peptide: 5’-CCC GGA TCC CAC TGC CCC 
AGT GAA CCC TCA GAGG-3’ and 5‘- CCC GAA TTC TTA 
AGA TGG CAC TAC CTC ACC AGG GTC T-3’ (BamHI and 
EcoRl restriction sites in bold, and target sequences underlined). 
For DGN-(30-438)-peptide: 5’-CCC GTC GAC CAC TGG 
CCC AGT GAA CCC TCA GAGG-3’ and 5’-CCC GAA TTC 
TTA TGA AGG CGT TGC TGG CTT TGG CGTG-3’ (Sull and 
EcoRl restriction sites in bold, and target sequences underlined). 
DNA sequences were cloned in a bacterial expression vector 
(pPEP) which permits high level of expression (Brandenberger 
et al., 1996) and contains an N-terminal His, tag and a thrombin 
cleavage site. Overnight cultures were diluted 1 : 100, grown up 
to an absorbance of 0.8 at 600 nm and then induced for 3-4 h 
with 1 mM isopropyl P-D-thiogalactopyranoside at 30°C. After 
cell lysis, proteins were purified using nickel nitrilotriacetate af- 
finity chromatography. The purified fusion proteins were incu- 
bated with thrombin (0.5 U/mg fusion protein) for 6 h at room 
temperature. Protein fragments of interest were finally separated 
from the carrier protein with a new passage on the same nickel 
column and collected in the flow-through and/or in the washing 
fraction. SDS/PAGE was used to check purity (Laemmli, 1970). 
Both DGN-(30- 180) and DGN-(30-438) peptides showed the 
expected sizes (respectively -16 kDa and =44.5 kDa) on SDS/ 
PAGE and their N-termini were checked by protein micro-se- 
quencing. Absorption coefficients [30000 M ~ cm-’ for DGN- 
(30-180)-peptide and 50000 M-’ cm-‘ for DGN-(30-438)- 
peptide] were measured using the method of Gill and von Hippel 
(1 989). 
Trypsin digestion. Protein samples (1-5 yM) were incu- 
bated with 16 nM trypsin at 22°C in 10 mM Tris, 150 mM NaCI, 
pH 7.4 (Tris/NaCI). Reactions were stopped at different times 
by incubating the sample in SDS buffer for 10 min at 95°C. 
Reaction products were analyzed by means of SDS/Tricine/ 
PAGE (Schagger and von Jagow, 1987). 
Fluorescence. Fluorescence emission spectra between 300- 
400 nm (excitation at 280 nm) were recorded at 22°C using a 
Jasco FP-777 spectrofluorimeter in 20 mM sodium phosphate 
pH 6.5 containing different concentrations of denaturating agent 
using a 0.5-cm cuvette. Protein concentration was 2 yM. Every 
measurement was made after at least 20 min of incubation with 
Gdn/HCI. Ultrapure Gdn/HCl was purchased from Nigu Chemie 
GmbH. 
Circular dichroism. Circular dichroic spectra were recorded 
at 22°C in a 0.2-cm quartz cell, using a Jasco 5-720 spectropo- 
larimeter. Spectra are the average of multiple accumulations. 
Spectra were noise-reduced using standard procedures and ex- 
pressed as mean molar residue ellipticity [ H I  (deg cm2 dmol ’) 
equal to [0],,,/(10 c . n . I ) ,  where [Q],,, is the measured elliptic- 
ity (mdeg), c is the protein concentration (M), n is the number 
of amino acid residueskhain, and 1 is the path-length of the cell 
(cm). 
Electron microscopy. Rotary shadowing experiments were 
performed as described by Engel (1994). Samples were exten- 
sively dialyzed against 100 mM NH,HCO, pH 7.9 and sprayed 
at a concentration of 10-20 pg/ml. 
Analytical ultracentrifugation. A Beckman model XLA 
analytical ultracentrifuge was employed. Sedimentation velocity 
runs were performed in 12-mm DS Epon cells at 56000 rpm 
at 20°C in 10 mM sodium phosphate, 150 mM NaCl pH 7.0. 
Sedimentation equilibrium runs were performed using the same 
cells also at 20°C but at a filling height of 2-3 mm only i n  
addition to FC-43 bottom fluid. Rotor speeds were adapted to 
the different molar masses: 32000 rpm for DGN-(30- 180)-pep- 
tide and 18000 rpm for DGN-(30-438)-peptide. Molar masses 
were determined using a computer program that adjusts the 
baseline absorbance to produce the best linear fit of InA versus 
rZ ( A  = absorbance, Y = distance from the rotor center). In all 
cases a partial specific volume of v = 0.73 ml/g was used. Sedi- 
mentation coefficients were corrected to the viscosity and den- 
sity of water using standard procedures (Van Holde, 1985). 
Solid-phase radio ligand-binding assays. A 95-kDa C-ter- 
mind fragment of chicken agrin which contains the 
two globular domains ((31 and G2) sufficient for a-dystroglycan 
binding was recombinantly expressed (Gesemann et al., 1996). 
Laminin-1 was purified from Engelbreth-HoIm-Swarm murine 
tumor (Paulsson et al., 1987) and iodinated as described by Ge- 
semann et al. (1996). Chicken skeletal muscle a-dystroglycan 
was purified from freshly frozen tissues using a protocol similar 
to that reported by Brancaccio et al. (1995a). 100 yl tissue-de- 
rived (at -5 nM concentration) or recombinant a-dystroglycan 
(at -20 nM concentration) were coated on microtiter plates by 
overnight incubation at 4°C in 50 mM NaHCO, pH 9.6. Agrin- 
binding experiments were performed in Tris/NaCI pH 7.4 con- 
taining 1.25 mM CaCI, and 1 mM MgCl, as described elsewhere 
with minor modifications (Gesemann et al., 1996). Each data- 
point represents the average of triplicate measurements. Unspe- 
cific binding (e.g. binding in the presence of an excess of unla- 
beled agrin fragment) was subtracted from each data point. Data 
referring to tissue-purified a-dystroglycan binding to agrin were 
fitted by nonlinear regression analysis using a single class of 
binding sites equation in which radioactivity (cpm) is equal to 
(c . B)/(K,  + c), where K ,  is the binding dissociation constant, 
c the concentration of c95,,,, and B is the radioactivity at total 
saturation. 
RESULTS 
a-Dystroglycan N-terminal fragments : expression and sta- 
bility. Fig. 1 shows an alignment of human, rabbit and mouse 
sequences. The N-terminus in the native protein is blocked, but 
His30 may be assigned as the first residue according to the pro- 
posed signal sequence (Ibraghimov-Beskrovnaya et al., 1992). 
Two recombinant fragments were prepared which start at His30. 
The first ends at position 180 and the second at position 438 
and its sequence contains part of the mucin-like region (Fig. 1). 
Fig. 2 shows SDSPAGE analysis of the fusion products 
purified by nickel affinity chromatography. Both DGN-(30- 
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Fig. 1. Primary structure of human, rabbit and mouse a-dystroglyeans. For rabbit and mouse only non-conserved residues are shown. DGN- 
(30- 180))peptide and DGN-(30-438)-peptide recombinantly expressed mouse sequences are underlined. The sequences proposed as signal peptides 
are also underlined (Ibraghimov-Beskrovnaya et al., 1992). Cys residues are marked by arrows, and Trp by closed circles. In the C- and N-terminal 
parts of the sequence potential sites for N-linked glycosylation are indicated by asterisks and putative 0-linked sites by open triangles. The central 
part of the sequence (residues 316-384) contains up to 40% of Pro and Thr residues, and is heavily glycosylated (see also Henry and Campbell, 
1996). 
180)-peptide and DGN-(30-438)-peptide fusion proteins were 
obtained directly in soluble form without using any denaturating 
agent. This is often considered as a first positive indication for 
the achievement of a correct folding in the expression of a re- 
combinant protein (Makride, 1996). Moreover, the protein frag- 
ments are still soluble after thrombin cleavage and purification 
(Fig. 3A and B). Some degradation was observed during DGN- 
(30-438)-peptide purification (data not shown). Partial se- 
quencing indicated the same N-terminus for these fragments, in- 
dicating that degradation occurred from the C-terminus and is 
possibly due to the absence of structure in the mucin-like region 
of the protein. Resistance to protease digestion of correctly 
folded domains is a common probe for proper folding of recom- 
binant fragments (Maurer et al., 1992; Pokutta et al., 1994). 
Limited proteolysis has been successfully used to investigate do- 
main organization of several multi-modular extracellular matrix 
proteins (Beck et al., 1990). 
After trypsin incubation, DGN-(30- 180)-peptide undergoes 
only a slight reduction of its molecular size (Fig. 3A). This re- 
sult indicates the presence of a significant amount of structural 
organization in the final 15-kDa fragment (Fig. 3A, arrow). 
DGN-(30-438)-peptide was cleaved into fragments of about 
30 kDa and 15 kDa (Fig. 3B, arrows). N-terminal micro-se- 
quencing indicated that the 30-kDa fragment starts from His30 
while the 15-kDa band contains two sequences starting from 
His30 and from Ala169. This indicates that the 30-kDa fragment 
is divided into two peptides of similar size. The first, residues 
30-168, is similar to the 15-kDa band observed as the proteo- 
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Fig. 2. Fusion protein purification. SDS/PAGE shows purification of 
His,-tagged fusion proteins using nickel nitrilotriacetate affinity chronia- 
tography. (A) DGN-(30- lSO)-peptide; lane 1, flow-through; lanes 2 and 
3, wash; lane 4, elution. (B) DGN-(30-438)-peptide; lane 1, flow- 
through; lane 2, wash, lanes 3 and 4, elution. Molecular masses of 
marker proteins are indicated at the left margin. 
Fig. 3. Trypsin digestion. SDS/Tricine/PAGE analysis after trypsin in- 
cubation at different times. (A) DGN-(30-180)-peptide is degraded to a 
slightly reduced ~nolecular size (=15 kDa, arrow). (B) DGN-(30-438)- 
peptide is divided in two fragments of 15 kDa and 30 kDa (arrows). 
Molecular masses of marker proteins are indicated at the left margin. 
lytically stable fragment of DGN-(30- 180)-peptide (Fig. 3 A) ; 
the second likely ends at a residue between positions 309-313 
(see Fig. 1 ) .  
DGN-(30-438)-peptide fluorescence and circular dichroism. 
The N-terminal region of a-dystroglycan contains tryptophan 
7wo 
A 
o !  I I 
Fig. 5. Electron microscopy of DGN-(30-438)-peptide after rotary 
shadowing. (A) A selection of DGN-(30-438)-peptide globular mole- 
cules is clearly visible. (B) Particles of DGN-(30-438)-peptide which 
occasionally show tails originating from the mucin-like C-terminal part. 
(C) Intact chicken muscle dumbbell-shaped a-dystroglycan molecules 
are shown for comparison (from Brancaccio et al., 1995a). The bar rep- 
resents 100 nm. 
residues in positions 31, 42, 107, 110, 260, and 297 (see Fig. 1) 
making DGN-(30-438)-peptide well suited to fluorescence 
analysis. Its emission maximum at 438 nm indicates that the 
tryptophan residues are buried in the protein structure (Schmid, 
1990), suggesting that DGN-(30-438)-peptide has a folded 
structure (Fig. 4A). Moreover, increasing concentrations of gua- 
nidinium hydrochloride (Gdn/HCI) produce a clear red-shift to 
455 nm (Fig. 4A) and a sharp and cooperative transition curve 
typical of an unfolding process (Fig. 4 B ;  Schmid, 1990). 
Circular dichroism of DGN-(30-438)-peptide was recorded 
at 22°C between 185-250 nm (Fig. 4C). This spectral shape 
indicates low levels of typical a or p secondary structures, and 
is similar to those recorded for loop-containing proteins: a posi- 
tive peak between 180- 185 nm and a reduction of negative sig- 
nal between 200-250 nm (for example elastase, see Johnson, 
1990). Denaturation also reduces the ellipticity of DGN-(30- 
438)-peptide (Fig. 4 C) and a Gdn/HCI transition curve similar 
to that shown in Fig. 4B  was obtained by circular dichroism 
(data not shown). 
DGN-(30-438)-peptide electron microscopy and analytical 
centrifugation. Electron microscopy is a powerful and com- 
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Fig. 4. Fluorescence and circular dichroism. (A) Fluorescence spectra of DGN-(30-438)-peptide as a function of GddHCI concentration : (A) 
none; (A) 4.5 M;  the other spectra (continuous lines) refer to 0.5, 0.75, 1, 1.2, 2 and 3.2 M. The maximum i s  red-shifted from 338 nm to 355 iim. 
(B) GddHCl denaturation of DGN-(30-438)-peptide monitored by reduction of fluorescence emission at 338 nm. The line refers to data fitting 
according to the equation proposed by Staniforth et al. (1993): the Gdn/HCI concentration at 50% of unfolding is ==I M. (C) Circular dichroic 
spectrum of DGN-(30-438)-peptide at 22"C, in 10 mM sodium phosphate pH 7.0 (continuous line), and in the presence of 2.8 M Gdn/HCI (dashed 
line). 
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Table 1. Analytical centrifugation of N-terminal mouse dystroglycan 
fragments. Frictional ratios f f o  for DGN-(30- 180))peptide and DGN- 
(30-438)-peptide calculated according to Van Holde (1985) suggest an 
overall globular structure for u-dystroglycan N-terminal domain. 
Peptide Conc. s2()* f&, Molecular m a s  
deter- fi (mi 
mined sequence 
pg/ml S kDa 
DGN-(30-180) 190 1.6 1.06 13.5 16.3 
DGN-(30-438) 180 2.6 1.38 41" 44.2 
The low value is explained by partial degradation in the mucin- 
like domain (see text). 
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Fig. 6. Solid-phase radioligand-binding assay. Chicken skeletal muscle 
a-dystroglycan binds with high affinity (& = 2 nM) to the C-terminal 
agrin fragment c9SA\08(J which contains the cx-dystroglycan-binding site 
(0) while no binding was detected to recombinant DGN-(30-438)-pep- 
tide (0). No binding was also detected to laminin-1 (A). 100-pl aliquots 
of native u-dystroglycan (at = 5 nM concentration) and DGN-(30-438)- 
peptide (at =20 nM) were coated on a microtiter plate and incubated 
with increasing concentrations of iodinated agrin fragment. Unspecific 
binding accounted for less than 5 % of the detected signals. 
monly used approach to visualize the shape of large extracellular 
matrix proteins (Engel, 1994). Rotary shadowing of purified 
DGN-(30-438)-peptide samples reveals the presence of mole- 
cules which have a globular shape and a homogeneous size 
(Fig. 5A).  These globes represent the N-terminal domain of a- 
dystroglycan (size = 30 kDa from trypsin experiment, Fig. 3 B). 
Thin rods extending from the globular domain are occasionally 
observed (Fig. 5 B), which most likely represent part of the mu- 
cin-like region. The dimensions of the recombinant N-terminal 
a-dystroglycan doinain are in agreement with those measured 
for intact a-dystroglycan (Fig. 5 C). 
Moreover, analytical ultracentrifugation data also indicate 
that the N-terminal part of a-dystroglycan has a globular shape. 
Experimental values (Table 1) indicate that both DGN-(3O- 
180)-peptide and DGN-(30-438)-peptide have frictional ratios 
in good accordance with values reported for globular molecules. 
The N-terminal domain of a-dystroglycan does not bind to 
agrin and laminin. In contrast to tissue-purified a-dystroglycan, 
DGN-(30-438)-peptide shows no interaction with a 95-kDa io- 
dinated C-terminal fragment of agrin in a solid-phase assay 
(Fig. 6). Moreover, increasing concentrations of soluble DGN- 
(30-438)-peptide (up to a few micromolar) were also unable to 
compete with the interaction between chicken skeletal muscle a- 
dystroglycan and the agrin fragment (data not shown). No bind- 
ing was detected either to iodinated laminin-I. 
DISCUSSION 
The main difficulty in elucidating the domain organization 
and the structural features of a-dystroglycan is due to the ab- 
sence of significant similarity to other proteins. On the basis of 
sequence analysis and electron microscopy data, we have pre- 
viously proposed that a-dystroglycan contains two globular do- 
mains separated by a central elongated mucin-like region (Bran- 
caccio et al., 199Sa). 
We were now able to express and study recombinant frag- 
ments of the a-dystroglycan N-terminal region. The results indi- 
cate that the region approximately between residues 30-315 is 
an independently folding globular domain as indicated by the 
expression in soluble form, the resistance against trypsin diges- 
tion, the electron microscopic and hydrodynamic shape and by 
a sharp denaturation profile. A fragment starting at His30 and 
ending at Ala300 was not soluble (data not shown), indicating 
that the loss of about 15 C-terminal residues prevents folding. 
Our data indicate that folding of the u-dystroglycan N-terminal 
domain is not prevented in the absence of glycosylation. 
A plausible schematic description of a-dystroglycan domain 
organization and of its N-terminal region is shown in Fig. 7. 
Analysis of the fragments obtained after trypsin incubation sug- 
gest two possible subdomains in the regions 30-160 and 180- 
315. They are separated by a stretch of poorly conserved resi- 
dues with characteristics of an exposed linker sequence (Fig. 1). 
A potential trypsin cleavage site is located at Arg168. 
Far-ultraviolet circular dichroism analysis suggests that the 
a-dystroglycan N-terminal domain has a loop-containing struc- 
ture. In fact, the DGN-(30-438)-peptide spectrum is similar to 
that reported for elastase, a well-known loop-containing matrix 
metallo-protease (Johnson, 1990). The sequence of a-dystrogly- 
can from His30 to Asn302 has an about 20% identity (not 
shown) with murine macrophage elastase (Shapiro et al., 1992). 
This identity range is in the 10-25% twilight zone in which 
unambiguous relationships are difficult to determine (Gray and 
Doolittle, 1992). Loop regions are defined as aperiodic segments 
which connect a-helices and p-strands. They are common in 
many proteins and often important functional sites are located 
on loops (Martin et al., 199.5). A loop-containing structure, stabi- 
lized by the presence of four disulfide bridges, was recently 
found in LE (EGF-like) domains of laminin which are involved 
in nidogen binding (Stetefeld et al., 2996). 
We have previously speculated that the N-terminal region of 
a-dystroglycan is oriented towards the extracellular space and 
thus represents the binding site to the extracellular matrix bind- 
ing partners (Brancaccio et al., 1995a; see also Henry and 
Campbell, 1996). Our data show that the recombinant a-dystro- 
glycan N-terminal domain does not bind to agrin and laminin in 
a nanomolar concentration range. This means either that the 
binding site is present in a different part of the molecule or that 
glycosylation is essential for binding. A crucial role of glycosy- 
lation for binding would confirm earlier experiments by Ervasti 
and Campbell (1993) and more recently by Chiba et al. (1997). 
It is unlikely however that the observed lack of laminin and 
agrin binding originates from the absence of glycosylation in the 
N-terminal globular region. The domain is poorly glycosylated 
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Fig. 7. a-Dystroglycan domain organization. The autonomous N-terminal domain is termined near residue 3 15. A cluster of non-conserved residues 
(see Fig. 1) and partial trypsin digestion indicate a spacer between two putative subdomains (residues 160-180). The site of observed trypsin 
cleavage (arrowhead) and putative N-glycosylation (asterisks) and 0-glycosylation (open triangles) sites are indicated. The mucin-like region which 
connects the N-terminal domain with a putative C-terminal domain in the dumbbell-shaped a-dystroglycan is shown. 
since only two putative sites are present (Ser90 and Asnl41). 
The highly glycosylated central mucin-like domain is a strong 
candidate for laminin and agrin binding. 
Biophysical and structural work including an X-ray diffrac- 
tion analysis can however be performed preferentially with none 
or only moderately glycosylated domains. Many structural 
studies were very successfully performed with proteins recombi- 
nantly expressed in E. coli, even when glycosylation sites were 
not occupied (Bork et al., 1996). Our present work demonstrates 
that a bacterially expressed N-terminal fragment of a-dystrogly- 
can contains its N-terminal autonomously folding domain. We 
have recently achieved very similar results with a somewhat 
smaller fragment (positions 30-315, see Figs 1 and 7) which 
lacks the mucin-like domain. This fragment also folded to a 
trypsin-resistant structure and was very homogeneous according 
to electron microscopy and ultracentrifugation. It will now be 
used for further structural investigations. 
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